Literature DB >> 28639394

Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier.

Maryam Ghadiri1, Ebrahim Vasheghani-Farahani1, Fatemeh Atyabi2, Farzad Kobarfard3, Farzaneh Mohamadyar-Toupkanlou4, Hossein Hosseinkhani5.   

Abstract

Application of many vital hydrophilic medicines have been restricted by blood-brain barrier (BBB) for treatment of brain diseases. In this study, a targeted drug delivery system based on dextran-spermine biopolymer was developed for drug transport across BBB. Drug loaded magnetic dextran-spermine nanoparticles (DS-NPs) were prepared via ionic gelation followed by transferrin (Tf) conjugation as targeting moiety. The characteristics of Tf conjugated nanoparticles (TDS-NPs) were analyzed by different methods and their cytotoxicity effects on U87MG cells were tested. The superparamagnetic characteristic of TDS-NPs was verified by vibration simple magnetometer. Capecitabine loaded TDS-NPs exhibited pH-sensitive release behavior with enhanced cytotoxicity against U87MG cells, compared to DS-NPs and free capecitabine. Prussian-blue staining and TEM-imaging showed the significant cellular uptake of TDS-NPs. Furthermore, a remarkable increase of Fe concentrations in brain was observed following their biodistribution and histological studies in vivo, after 1 and 7 days of post-injection. Enhanced drug transport across BBB and pH-triggered cellular uptake of TDS-NPs indicated that these theranostic nanocarriers are promising candidate for the brain malignance treatment.
© 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 2851-2864, 2017. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  biodistribution; capecitabine; cationic polymer; pH-sensitive; targeted delivery

Mesh:

Substances:

Year:  2017        PMID: 28639394     DOI: 10.1002/jbm.a.36145

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  10 in total

Review 1.  Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.

Authors:  Liron L Israel; Anna Galstyan; Eggehard Holler; Julia Y Ljubimova
Journal:  J Control Release       Date:  2020-01-07       Impact factor: 9.776

Review 2.  Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.

Authors:  Hira Choudhury; Manisha Pandey; Pei Xin Chin; Yee Lin Phang; Jeng Yuen Cheah; Shu Chien Ooi; Kit-Kay Mak; Mallikarjuna Rao Pichika; Prashant Kesharwani; Zahid Hussain; Bapi Gorain
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 3.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

4.  Overcoming blood-brain barrier transport: Advances in nanoparticle-based drug delivery strategies.

Authors:  Shichao Ding; Aminul Islam Khan; Xiaoli Cai; Yang Song; Zhaoyuan Lyu; Dan Du; Prashanta Dutta; Yuehe Lin
Journal:  Mater Today (Kidlington)       Date:  2020-03-04       Impact factor: 31.041

Review 5.  Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.

Authors:  Weisen Zhang; Ami Mehta; Ziqiu Tong; Lars Esser; Nicolas H Voelcker
Journal:  Adv Sci (Weinh)       Date:  2021-03-07       Impact factor: 16.806

Review 6.  Use of Super Paramagnetic Iron Oxide Nanoparticles as Drug Carriers in Brain and Ear: State of the Art and Challenges.

Authors:  Caroline Guigou; Alain Lalande; Nadine Millot; Karim Belharet; Alexis Bozorg Grayeli
Journal:  Brain Sci       Date:  2021-03-11

Review 7.  Nanocomposites as biomolecules delivery agents in nanomedicine.

Authors:  Magdalena Bamburowicz-Klimkowska; Magdalena Poplawska; Ireneusz P Grudzinski
Journal:  J Nanobiotechnology       Date:  2019-04-03       Impact factor: 9.429

Review 8.  Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer.

Authors:  Chengyuan Zhang; Xuemei Zhou; Hanyi Zhang; Xuanliang Han; Baijun Li; Ran Yang; Xing Zhou
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

Review 9.  Overcoming the blood-brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches.

Authors:  Ksenia Mitusova; Oleksii O Peltek; Timofey E Karpov; Albert R Muslimov; Mikhail V Zyuzin; Alexander S Timin
Journal:  J Nanobiotechnology       Date:  2022-09-15       Impact factor: 9.429

Review 10.  Tailoring Iron Oxide Nanoparticles for Efficient Cellular Internalization and Endosomal Escape.

Authors:  Laura Rueda-Gensini; Javier Cifuentes; Maria Claudia Castellanos; Paola Ruiz Puentes; Julian A Serna; Carolina Muñoz-Camargo; Juan C Cruz
Journal:  Nanomaterials (Basel)       Date:  2020-09-11       Impact factor: 5.076

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.